TM iD Application - Characterization of Human Gastric Cancer by MALDI Imaging
From LEAP
Current revision (23:28, 26 May 2010) (view source) |
|||
(One intermediate revision not shown.) | |||
Line 10: | Line 10: | ||
---- | ---- | ||
- | + | {{logo}} | |
=== Contact LEAP === | === Contact LEAP === | ||
+ | {{contact|topic=LEAP and the PAL Platform}} | ||
- | + | ''The information and references contained in this web site are believed to be accurate and the most current information available.'' | |
- | + | ||
- | + | ||
<br><br> | <br><br> | ||
[[Category:TM iD]] | [[Category:TM iD]] | ||
[[Category:MALDI]] | [[Category:MALDI]] | ||
[[Category:Glossary]] | [[Category:Glossary]] | ||
+ | [[Category:Proteomics]] |
Current revision
TM iD Application - Characterization of Human Gastric Cancer by MALDI Imaging
Characterization of Human Gastric Cancer by MALDI Imaging
Sören-Oliver Deininger, Martin Schürenberg, Matthias Ebert, ChristophRöcken 1Bruker Daltonik GmbH, Bremen, Germany; 2Department of Medicine II, KlinikumrechtsderIsar, Technical University of Munich, Germany; 3Institute of Pathology, CharitéUniversity Hospital, Berlin, Germany
Presented at ABRF 2006
Introduction: MALDI imaging is an emerging technology with the potential to find biomarkers directly on tissue and measure the spatial distribution of biomarkers across the tissue [1]. Here we used MALDI imaging for the analysis of human gastric cancer samples and evaluated the effect of different sample preparation methods.
Contact LEAP
![]() For additional information about LEAP and the PAL Platform, please contact LEAP Technologies. |
The information and references contained in this web site are believed to be accurate and the most current information available.